Stock data

大江 (8436)

大江 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$520.66M, down 16.1% from a year earlier. EPS over the last four quarters totals NT$9.42.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 大江 in Insightr